References
- Gunderson LL, Burch PA, Donohue JH. The Role of Irradiation as a Component of Combined Modality Treatment for Gastric Carcinoma. J Infus Chemother 1995; 5: 117-24.
- Gunderson LL, Sosin H. Adenocarcinoma of the stomach: Areas of failure in a reoperation series (second or symptomatic look) clinicopathological correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982; 8: 1-11.
- Smalley SR, Gunderson L, Tepper J, Martenson JA Jr, Minsky B, Willett C, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002; 52: 283-93.
- Willett CG, Gunderson LL. Stomach. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology, 5th edition. Philadelphia: Lippincott-Raven Publishers; 2008. p. 1318-35.
- Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
- Bora H, Unsal D, Akmansu M. Results of chemoirradiation after curative resection of locally advanced gastric cancer. Int J Clin Pract 2004; 58: 451-6.
- Moertel CG, Childs DS, O'Fallon JR, Holbrook MA, Schutt AJ, Reitemeier RJ. Combined 5-fluorouracil and radiation therapy as a surgical adjuvant for poor prognosis gastric carcinoma. J Clin Oncol 1984; 2: 1249-54.
- Hughes BG, Yip D, Chao M, Gibbs P, Carroll S, Goldstein D, et al. Audit of postoperative chemoradiotherapy as adjuvant therapy for resected gastroesophageal adenocarcinoma: an Australian multicentre experience. ANZ J Surg 2004; 74: 951-6.
- Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, et al. Postoperative chemotherapy for gastric cancer. Ann Oncol 2003; 14: 1373-7.
- Oblak I, Velenik V, Anderluh F, Strojan P. Results of adjuvant radiochemotherapy for gastric adenocarcinoma in Slovenia. Eur J Surg Oncol 2007; 33: 982-7.
- Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, et al. The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU. Tumori 2008; 94: 70-4.
- Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, et al. Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group. J Cancer Res Clin Oncol 2009; 135: 163-72.
- Baeza MR, Giannini TO, Rivera SR, Gonzalez P, Gonzalez J, Vergara E, et al. Adjuvant radiochemotherapy in the treatment of completely resected, locally advanced gastric cancer. Int J Radiat Oncol Biol Phys 2001; 50: 645-50.
- Beşe NS, Büyükünal E, Özgüro lu M, Demir G, Yildirim A, Mandel NM, et al. Toxicity and survival results of a phase II study investigating the role of postoperative chemoradioimmunotherapy for gastric adenocarcinoma. Strahlenther Onkol 2005; 181: 652-9.
- Bleiberg H, Goffin JC, Dalesio O, Buyse M, Pector JC, Gignoux M, et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer: A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC. Eur J Surg Oncol 1989; 15: 535-43.
- Lim DH, Kim DY, Kang MK, Kim YI, Kang WK, Park CK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncology's view. Br J Cancer 2004; 91: 11-7.
- Earle CC, Maroun J, Zuraw L; Cancer Care Ontario Practice Guidelines Initiative Gastrointestinal Cancer Disease Site Group. Neoadjuvant or adjuvant therapy for resectable gastric cancer? A practice guideline. Can J Surg 2002; 45: 438-46.
- Jansen EP, Saunders MP, Boot H, Oppedijk V, Dubbelman R, Porritt B, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys 2007; 67: 781-5.
- Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 1990; 8: 147-59
- Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
- Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
- Cox DR. Regression models and life-tables. J R Stat Soc Bull 1972; 34: 187-220.
- MacDonald JS. Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol 2005; 90: 166-70.
- Kovač V, Smrdel U. Meta-analyses of clinical trials in patients with non-small cell lung cancer. Neoplasma 2004; 51: 334-40.
- Debevec L, Jerič T, Kovač V, Bitenc M, Sok M. Is there any progress in routine management of lung cancer patients? A comparative analysis of an institution in 1996 and 2006. Radiol Oncol 2009; 43: 47-53.
- Yao JC, Mansfield PF, Pisters PW, Feig BW, Janjan NA, Crane C, et al. Combined-modality therapy for gastric cancer. Semin Surg Oncol 2003; 21: 223-7.
- Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer. Gastric Cancer 1998; 1: 125-33.
- DeVita VT Jr, Chu E. Principles of Medical Oncology. In: DeVita VT Jr, Lawrence TS, Rosenberg SA, editors. Cancer: principle and practice of oncology, 8th edition. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 337-50.
- Kragelj B. Increased late urinary toxicity with whole pelvic radiotherapy after prostatectomy. Radiol Oncol 2009; 43: 88-96.
- Stavrev P, Schinkel C, Stavreva N, Fallone BG. How well are clinical gross tumor volume DVHs approximated by an analytical function? Radiol Oncol 2009; 43: 132-5.
- Velenik V. Locally recurrent rectal cancer: treatment options. Radiol Oncol 2009; 43: 144-51.